Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib Phase 2a dose-ranging in RA
NCT01668641Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- May 2012
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of filgotinib in rheumatoid arthritis (RA), sponsored by Galapagos NV. Started May 2012; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01668641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668641.